Verified stock metrics
CRISPR Therapeutics Key Stock Metrics
Direct answer
CRISPR Therapeutics has 8 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 21, 2026.
Get free CRISPR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $4.82B
- Price-to-book ratio
- 2.76x
- Return on equity
- -26.1%
- Dividend yield
- 0%
- 52-week price range
- $44.12 to $70.74
- Revenue growth
- 1,041.4%
- Profit margin
- 0%
- Debt-to-equity ratio
- 44.87%
Explore related company data
View CRISPR Therapeutics's market capitalizationView CRISPR Therapeutics's price-to-book ratioView CRISPR Therapeutics's return on equityView CRISPR Therapeutics's dividend yieldView CRISPR Therapeutics's 52-week price rangeView CRISPR Therapeutics's revenue growthView CRISPR Therapeutics's profit marginView CRISPR Therapeutics's debt-to-equity ratioReturn to CRISPR Therapeutics profile